Current observations on the Pipeline Embolization Device for intracranial aneurysms

Current case series have suggested that the Pipeline Embolization Device [PED] is a safe and effective treatment. Over 90% total obliteration rate at 12 months have been consistently confirmed among studies. However, uncertainty still remains in predicting the risk of, and preventing delayed rupture and thrombotic occlusion, writes George Kwok-chu Wong, Hong Kong, China, in this opinion editorial.

Stroke risk high when anti-clotting drugs stopped

Some patients with certain types of atrial fibrillation who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association’s Emerging Science Series webinar.

1 Mission 1 Million initiative works to improve stroke prevention in atrial fibrillation

1 Mission 1 Million – Getting to the Heart of Strokeannounced plans to launch a new phase of the initiative dedicated to raise awareness of atrial fibrillation and its link to stroke. Community-based action is at the heart of this global initiative and during 2012 the campaign will continue to support projects around the world.

Patient-specific cerebral artery model for simulating neurointervention

Makoto Negoro, professor, Fujita Health University, School of Medicine, Toyoake-Nagoya, Japan, tells NeuroNews that simulation-based training is beginning to receive great attention in surgery and endovascular intervention. He says the simulator, called EVE, which takes its initials from EndoVascular Evaluator, is able to analyse the process and the result of an intervention performed by a trainee.

Neuro NEWS. The international newspaper for neurointerventionists

Giant aneurysms and flow diversion, five years of follow-up

Giant aneurysms are defined as those whose maximum diameter exceeds 2.5cm. The natural history of these lesions is associated with high morbidity and mortality rates. The first report on giant aneurysms dates back to 1875, written by Hutchinson. In the large patient series based reports of Drake and Sundt, published between 1979 and 1991, they were considered as being operable with an acceptable morbidity-mortality rate.